ARUNIMA BISWAS
Also known as: Arunima
University of Kalyani, dinabandhu mahavidyalaya bongaon, Indian Institute of Chemical Biology CSIR
0000-0001-5099-6756
About
Dr. Arunima Biswas is working as Assistant Professor, Department of Zoology, University of Kalyani since November 2015. She completed her Masters in Zoology from University of Calcutta in 2005. She obtained her Ph.D. degree in 2010 from CSIR-Indian Institute of Chemical Biology (CSIR-IICB) where she worked on molecular mechanisms of cAMP signalling in the unicellular protozoan parasite Leishmania as CSIR-research fellow after qualifying CSIR-NET. She was awarded with DST-INSPIRE Faculty Fellowship and joined CSIR-IICB as a DST-INSPIRE Faculty in December 2012. There she started working as an independent PI on Cell Cycle Regulation of Leishmania in context of cAMP signalling. In March 2015, she joined Dinabandhu Mahavidyalaya as an assistant professor in the Department of Zoology. Later in 2015, she joined University of Kalyani. She has publications in renowned international journals like Journal of Cellular Biochemistry (IF 4.2), Journal of Molecular Liquids (IF 6.6) Free Radical Biology and Medicine (Impact Factor: 5.8), Journal of Immunology (Impact Factor: 4.98), European Journal of Immunology (Impact Factor: 4.2), Frontiers in Pharmacology (Impact Factor: 5.4) Journal of Biological Chemistry (Impact Factor: 4.3) and International Journal of Biochemistry and Cell Biology (Impact Factor: 3.9). Though, she is working on role of cyclic nucleotide signalling in the cell cycle regulation of a protozoan parasite Leishmania, her recent research interest also includes understanding the role of cyclic nucleotide signalling in cancer stem cells and targeting cancer stem cells with cyclic nucleotide-dependent phosphodiesterase inhibitors.
Employment
-
University of Kalyani Assistant Professor2015 - Present
-
dinabandhu mahavidyalaya bongaon assistant Professor2015 - 2015
-
Indian Institute of Chemical Biology CSIR DST-INSPIRE Faculty2012 - 2015
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (50)
- Development of bioactive mono and binuclear copper(II) complexes as DNA binder, antimicrobial and anticancer materials Save
- Synthesis and Cellular Evaluation of Some Oxepino‐ and Pyranoxanthone Derivatives as Antitumor Agents: A Comparative Study Save
- A systemic immunoinformatics approach to design combinatorial multiepitope vaccine candidates against vector-borne bacterial infections exploiting the proteomes of the causative agent and vector for scrub typhus Save
- A multifaceted examination of the action of PDE4 inhibitor rolipram on MMP2/9 reveals therapeutic implications Save
- Metal Oxide–Enhanced Para-Coumaric Acid Nanoparticles for Precision Targeting of Leishmania donovani Save
- PDE4 inhibitor rolipram represses hedgehog signaling via ubiquitin-mediated proteolysis of GLI transcription factors to regress breast cancer Save
- Phosphodiesterase 4 as a candidate therapeutic target of cancer Save
- Rhodamine hydrazide-linked naphthalimide derivative: Selective naked eye detection of Cu2+, S2− and understanding the therapeutic potential of the copper complex as an anti-cervical cancer agent Save
- Modulation and Determination of the Status of Inflammasomes in Leishmania-Infected Macrophages Save
- Repurposing approved protein kinase inhibitors as potent anti-leishmanials targeting Leishmania MAP kinases Save